| 3Rs | to replace, reduce, and refine (or replacement, reduction, and refinement of) the use of animal models |
| ADME | absorption, distribution, metabolism and excretion |
| ATSDR | Agency for Toxic Substances and Disease Registry |
| AUC | area under curve |
| BMD | benchmark dose, the dose of a chemical that is required to achieve a predetermined response of a toxicological effect |
| BMD10 | derived benchmark dose that is associated with a 10% extra risk of adverse effect in the exposed test animals |
| BMDL10 | the lower bound of 95% confidence interval on BMD10 |
| CFSAN | FDA Center for Food Safety and Applied Nutrition |
| Cmax | the highest concentration of a chemical in the blood or a tissue after a dose is given |
| CPSC | U.S. Consumer Product Safety Commission |
| Css | steady-state concentration |
| DoD | U.S. Department of Defense |
| EAD | equivalent administered dose |
| ENM | engineered nanomaterial |
| EPA | U.S. Environmental Protection Agency |
| ER | estrogen receptor |
| EURL-ECVAM | European Union Reference Laboratory for Alternatives to Animal Testing |
| FDA | U.S. Food and Drug Administration |
| HTS | high throughput screening |
| HT-IVIVE | high throughput in vitro to in vivo extrapolation |
| ICCVAM | Interagency Coordinating Committee on the Validation of Alternative Methods |
| ICE | Integrated Chemical Environment |
| IVIVE | in vitro to in vivo extrapolation |
| IVIVE-WG | ICCVAM in vitro to in vivo Extrapolation Workgroup |
| LOAEL | low observed adverse effects level |
| log Kow | the n-octanol / water partition ratio or coefficient |
| NAM | new approach methodology |
| NIEHS | National Institute of Environmental Health Sciences |
| NIST | National Institute of Standards and Technology |
| NLM | U.S. National Library of Medicine |
| NOAEL | no observed adverse effect level |
| NOEL | no observed effect level |
| NTP | National Toxicology Program |
| OECD | Organisation for Economic Co-operation and Development |
| OED | oral equivalent dose |
| OPP | EPA Office of Pesticide Programs |
| QSAR | quantitative structure activity relationship |
| PD | pharmacodynamics |
| PK | pharmacokinetics |
| PBK | physiologically based kinetics |
| PBPK | physiologically based pharmacokinetics |
| PBTK | physiologically based toxicokinetics |
| PFOA | perfluorooctanoic acid |
| POD | point of departure |
| ToxCastTM | Toxicity forecaster |
| Tox21 | Toxicology in the 21st century |